Molecular and biochemical heterogeneity of class B carbapenem- hydrolyzing β-lactamases in Chryseobacterium meningosepticum

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1878-1886

  Bellais, Samuel ^a   Aubert, Daniel ^a   Naas, Thierry ^a   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMOXICILLIN; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHROMOSOME PROTEIN; IMIPENEM; KANAMYCIN; LATAMOXEF; MEROPENEM; NEOMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; TICARCILLIN; UREIDOPENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CHROMOSOME; CHRYSEOBACTERIUM; CHRYSEOBACTERIUM MENINGOSEPTICUM; CONTROLLED STUDY; DNA BASE COMPOSITION; DRUG HYDROLYSIS; ENZYME ACTIVITY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; STENOTROPHOMONAS MALTOPHILIA; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLONING, MOLECULAR; DNA, BACTERIAL; FLAVOBACTERIUM; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0033946586     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1878-1886.2000     Document Type: Article

References (58)

1. Alksne, L. E., and B. A. Rasmussen. 1997. Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon. J. Bacteriol. 179:2006-2013.
2. Ambler, R. P. 1980. The structure of beta-lactamases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 289:321-331.
3. IMP. Antimicrob. Agents Chemother. 39: 1612-1615.
4. Avidor, B., Y. Kletter, S. Abulafia, Y. Golan, M. Ephros, and M. Giladi. 1997. Molecular diagnosis of cat scratch disease: a two-step approach. J. Clin. Microbiol. 35:1924-1930.
5. Bellais, S., S. Léotard, L. Poirel, T. Naas, and P. Nordmann. 1999. Molecular characterization of a carbapenem-hydrolyzing β-lactamase from Chryseobacterium (Flavobacterium) indologenes. FEMS Microbiol. Lett. 171:127-132.
6. Bellais, S., L. Poirel, T. Naas, D. Girlich, and P. Nordmann. 2000. Genetic-biochemical analysis and distribution of the Ambler class A β-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob. Agents Chemother. 44:1-9.
7. Bloch, K. C., R. Nadarajah, and R. Jacobs. 1997. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 76:30-41.
8. Bush, K. 1998. Metallo-beta-lactamases: a class apart. Clin. Infect. Dis. 27(Suppl. 1):S48-S53.
9. Bush, K., and G. A. Jacoby. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
10. Carfi, A., S. Pares, E. Duee, M. Galleni, C. Duez, J.-M. Frère, and O. Dideberg. 1995. The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 14:4914-4921.
11. Colding, H., J. Bangsborg, N. E. Fiehn, T. Bennekov, and B. Bruun. 1994. Ribotyping for differentiating Flavobacterium meningosepticum isolates from clinical and environmental sources. J. Clin. Microbiol. 32:501-505.
12. Concha, N. O., B. A. Rasmussen, K. Bush, and O. Herzberg. 1996. Crystal structure of the wide-spectrum binuclear zinc metallo-β-lactamase from Bacteroides fragilis. Structure 4:823-836.
13. Cornish-Bowden, A. 1995. Graphs of the Michaelis-Menten equation, p. 30-37. In Fundamentals of enzyme kinetics. Portland Press, Inc., Seattle, Wash.
14. Da Silva, G. J., and R. Leitāo. 1999. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J. Clin. Microhiol. 37: 2109-2110.
15. Felici, A., G. Amicosante, A. Oratore, R. Strom, P. Ledent, B. Joris, L. Fanuel, and J. M. Frère. 1993. An overview of the kinetic parameters of class B β-lactamases. Biochem. J. 291:151-155.
16. Fraser, S. L., and J. H. Jorgensen. 1997. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob. Agents Chemother. 41:2738-2741.
17. George, R., C. Cochran, and W. Wheeler. 1961. Epidemic meningitis of the newborn caused by Flavobacterium. Am. J. Dis. Child. 101:296-304.
18. Hansen, J. B., and R. H. Olsen. 1978. Isolation of large bacterial plasmids and characterization of the P2 incompatibility group plasmids pMG1 and pMG5. J. Bacteriol. 135:227-238.
19. Hewick, R. M., M. W. Hunkapiller, D. Le Hoo, and W. J. Dreyer. 1981. A gas-liquid solid phase peptide and protein sequenator. J. Biol. Chem. 256: 7990-7997.
20. Hussain, M., A. Carlino, M. J. Madonna, and J. O. Lampen. 1985. Cloning and sequencing of the metallothioprotein β-lactamase II gene of Bacillus cereus 569/H in Escherichia coli. J. Bacteriol. 164:223-229.
21. IMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother. 39:824-829.
22. Iyobe, S., H. Yamada, and S. Minami. 1996. Insertion of a carbapenemase gene cassette into an integron of a Pseudomonas aeruginosa plasmid. J. Antimicrob. Chemother. 38:1114-1115.
23. Jones, R. N., M. A. Pfaller, S. A. Marshall, R. J. Hollis, and W. W. Wilke. 1997. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Diagn. Microbiol. Infect. Dis. 29:187-192.
24. Kado, C. I., and S. T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
25. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
26. IMP-containing Pseudomonas aeruginosa integron phyletically related to In5. which carries an unusual array of gene cassettes. Antimicrob. Agents Chemother. 43:890-901.
27. Laraki, N., N. Franceschini, G. M. Rossolini, P. Santucci, C. Meunier, E. de Pauw, G. Amicosante, J.-M. Frère, and M. Galleni. 1999. Biochemical characterization of the Pseudomonas aeruginosa 101/477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrob. Agents Chemother. 43: 902-906.
28. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
29. Lim, H. M., J. J. Pene, and R. Shaw. 1988. Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 β-lactamase II structural gene. J. Bacteriol. 170:2873-2878.
30. Livermore, D. M. 1997. Acquired carbapenemases. J. Antimicrob. Chemother. 39:673-676.
31. Massidda, O., G. M. Rossolini, and G. Satta. 1991. The Aeromonas hydrophila cphA gene: molecular heterogeneity among metallo-β-lactamases. J. Bacteriol. 173:4611-4617.
32. Matsumura, N., S. Minami, Y. Watanabe, S. Iyobe, and S. Mitsuhashi. 1999. Role of permeability in the activities of β-lactams against gram-negative bacteria which produce a group 3 β-lactamase. Antimicrob. Agents Chemother. 43:2084-2086.
33. Medeiros, A. A. 1997. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin. Infect. Dis. 24 (Suppl. 1):S19-S45.
34. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
35. Nordmann, P., and T. Naas. 1994. Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrob. Agents Chemother. 38:104-114.
36. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
37. Palissa, H., H. von Dohren, H. Kleinkauf, H. H. Ting, and J. E. Baldwin. 1989. Beta-lactam biosynthesis in a gram-negative eubacterium: purification and characterization of isopenicillin N synthase from Flavobacterium sp. strain SC 12.154. J. Bacteriol. 171:5720-5728.
38. Payne, D. J., R. Cramp, J. H. Bateson, J. Neale, and D. Knowles. 1994. Rapid identification of metallo-and serine beta-lactamases. Antimicrob. Agents Chemother. 38:991-996.
39. Pickett, M. J. 1989. Methods for identification of flavobacteria. J. Clin. Microhiol. 27:2309-2315.
40. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43:769-776.
41. Poirel, L., T. Naas, M. Guibert, E. B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581.
42. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
43. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
44. Rasmussen, B. A., Y. Gluzman, and F. P. Tally. 1990. Cloning and sequencing of the class B β-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob. Agents Chemother. 34:1590-1592.
45. CME) encoding an extended-spectrum class A β-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases. Antimicrob. Agents Chemother. 43:2193-2199.
46. Rossolini, G. M., N. Franceschini, M. L. Riccio, P. S. Mercuri, M. Perilli, M. Galleni. J.-M. Frère, and G. Amicosante. 1998. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B β-lactamase showing a broad substrate profile. Biochem. J. 332:145-152.
47. Saino, Y., F. Kobayashi, M. Inoue, and S. Mitsuhashi. 1982. Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22:564-570.
48. Sanschagrin, F., J. Dufresne, and R. C. Levesque. 1998. Molecular heterogeneity of the L-1 metallo-β-lactamase family from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:1245-1248.
49. Segatore, B., O. Massidda, G. Satta, D. Setacci, and G. Amicosante. 1993. High specificity of cphA-encoded metallo-beta-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to beta-lactam resistance. Antimicrob. Agents Chemother. 37:1324-1328.
50. IMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913.
51. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.
52. Siegman-Igra, Y., D. Schwartz, G. Soferman, and N. Konforti. 1987. Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med. Microbiol. Immunol. 176:103-111.
53. Swofford, D. L. 1989. PAUP (version 3.0): phylogenetic analysis using parsimony. Illinois Natural History Survey, Champaign, Ill.
54. Tarentino, A. L., G. Quinones, W. P. Schrader, L. M. Changchien, and T. H. Plummer, Jr. 1992. Multiple endoglycosidase (Endo) F activities expressed by Flavobacterium meningosepticum. Endo F1: molecular cloning, primary sequence, and structural relationship to Endo H. J. Biol. Chem. 267:3868-3872.
55. Ullah, J. H., T. R. Walsh, I. A. Taylor, D. C. Emery, C. S. Verma, S. J. Gamblin, and J. Spencer. 1998. The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution. J. Mol. Biol. 284:125-136.
56. Vandamme, P., J. F. Bernardet, P. Segers, K. Kersters, and B. Holmes. 1994. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int. J. Syst. Bacteriol. 44:827-831.
57. Walsh, T. R., L. Hall, S. J. Assinder, W. W. Nichols, S. J. Cartwright, A. P. MacGowan, and P. M. Bennett. 1994. Sequence analysis of the L-I metallo β-lactamase from Xanthomonas maltophilia. Biochim. Biophys. Acta 1218: 199-201.
58. Wang, Z., W. Fast, and S. J. Benkovic. 1999. On the mechanism of the metallo-β-lactamase from Bacteroides fragilis. Biochemistry 38:10013-10023.